Clinical Case Series of Decrease in Shear Wave Elastography Values in Ten Diabetic Dyslipidemia Patients Having NAFLD with Saroglitazar 4 mg: An Indian Experience

Table 3

Change in biochemical/clinical parameters and SWV values at baseline and after 9-month treatment with Saroglitazar 4 mg once daily.

	Baseline	9 months	Change from baseline	value
Waist circumference (inches)	37.6 ± 3.138	37.51 ± 3.123	−0.09	0.54
BMI (kg/m^2)	25.21 ± 3.07	24.81 ± 2.95	−0.4	0.046
FBG (mg/dL)	139.5 ± 15.67	106.5 ± 14.94	−33	<0.0001
HbA1c (%)	7.8 ± 0.343	6.9 ± 0.33	−0.9	<0.0001
TG (mg/dL)	298.2 ± 35.75	202.4 ± 13.19	−95.8	<0.0001
HDL-C (mg/dL)	40.79 ± 5.63	45.2 ± 4.36	4.4	0.0007
ALT (U/L)	64.7 ± 15.56	46.2 ± 12.6	−18.5	0.0058
AST (U/L)	43.4 ± 10.48	35.4 ± 6.59	−8	0.0321
SWV (M/S)	1.837 ± 0.0691	1.645 ± 0.0844	−0.192	0.0004
SBP (mmHg)	136 ± 6.04	134.6 ± 7.24	−1.4	0.0445

n = 10; data are mean ± SD; paired “t” test.